Literature DB >> 1343765

Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides.

T R Vrabec1, D S Gregerson, H S Dua, L A Donoso.   

Abstract

S-Antigen, a photoreceptor cell protein, is highly efficient in inducing experimental autoimmune uveoretinitis (EAU), a severe inflammation of the uveal tract and retina of the eye. S-Antigen and six synthetic peptides, all of which correspond to known T-cell or B-cell recognition sites, were tested for their ability to induce oral tolerance to EAU in LEW rats. Feeding three 1-mg doses of native S-Antigen or three doses of one synthetic peptide, designated BSA(343-362) (200 micrograms per dose), reduced the incidence and severity of EAU induced by immunization with 50 micrograms of S-Antigen. Another peptide, BSA(270-289), was able to inhibit EAU only when a low dose (10 micrograms) of the uveitogenic S-Antigen was used to induce EAU. Animals which received 200 micrograms doses of four other immunologically active peptides, BSA(31-51), BSA(143-162), BSA(303-327) and BSA(333-352), were not significantly protected. Furthermore, animals fed BSA(343-362) were significantly less susceptible to EAU induced by adoptive transfer (tEAU) of the uveitogenic R9 T-cell lines. Con A-activated lymphocytes purified from spleens of rats fed peptide BSA(343-362) transferred partial resistance to tEAU induced by adoptive transfer of R9 line cells. The resistance of orally tolerized rats to induction of EAU by adoptive transfer of an activated, pathogenic T-cell line, and the ability of lymphocytes from orally-tolerized animals to transfer resistance to tEAU shows that effector mechanisms can be inhibited by oral feeding as well as the afferent mechanisms reported here and elsewhere. Circulating levels of IgG specific for S-Antigen were not affected by feeding any of the peptides.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1343765     DOI: 10.3109/08916939209148457

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  11 in total

Review 1.  Ocular allergy treatments.

Authors:  L Bielory
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.

Authors:  B Laliotou; J Liversidge; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

3.  Tolerance to melanin-associated antigen in autoimmune uveitis is mediated by CD4+CD25+ T-regulatory cells.

Authors:  Bharati Matta; Purushottam Jha; Puran S Bora; Nalini S Bora
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

Review 4.  Cellular and molecular mechanisms in the two major forms of inflammatory bowel disease.

Authors:  Laszlo Bene; Andras Falus; Noemi Baffy; Andras Kristof Fulop
Journal:  Pathol Oncol Res       Date:  2011-06-17       Impact factor: 3.201

Review 5.  Antigen-specific therapies for the treatment of autoimmune diseases.

Authors:  D A Hafler; H L Weiner
Journal:  Springer Semin Immunopathol       Date:  1995

Review 6.  Oral desensitisation in rheumatoid arthritis.

Authors:  T L Vischer; W Van Eden
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

Review 7.  Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?

Authors:  A D Dick
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

Review 8.  Ocular allergy guidelines: a practical treatment algorithm.

Authors:  Leonard Bielory
Journal:  Drugs       Date:  2002       Impact factor: 9.546

9.  Ocular surface epithelium induces expression of human mucosal lymphocyte antigen (HML-1) on peripheral blood lymphocytes.

Authors:  J A P Gomes; H S Dua; L V Rizzo; M Nishi; A Joseph; L A Donoso
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

10.  Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis.

Authors:  A D Dick; Y F Cheng; J Liversidge; J V Forrester
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.